Glypican 2產(chǎn)品信息
英文名稱:Glypican-2
中文名稱:磷脂酰肌醇蛋白2
靶點(diǎn)別稱:Glypican 2,GPC2
物種:Human/Mouse/Rhesus macaque
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Glypican 2用戶評(píng)價(jià)
Glypican 2分子背景
Glypican 2(GPC2),也稱為腦多糖,是一種在發(fā)育中的神經(jīng)系統(tǒng)中發(fā)現(xiàn)的與糖磷脂酰肌醇連接的完整膜硫酸乙酰肝素蛋白多糖。腦聚糖參與細(xì)胞粘附,被認(rèn)為調(diào)節(jié)軸突的生長(zhǎng)和引導(dǎo)。腦聚糖對(duì)層粘連蛋白-1具有特別高的親和力。GPC2沉默使Wnt/β-catenin信號(hào)失活,并降低神經(jīng)母細(xì)胞瘤發(fā)生的致癌驅(qū)動(dòng)因素N-Myc的表達(dá)。靶向GPC2的免疫毒素和嵌合抗原受體(CAR)T細(xì)胞在小鼠模型中抑制神經(jīng)母細(xì)胞瘤的生長(zhǎng)。GPC3特異性抗體-藥物偶聯(lián)物(ADC)也可以抑制神經(jīng)母細(xì)胞瘤細(xì)胞增殖。
關(guān)鍵字: Glypican 2;Glypican 2蛋白;Glypican 2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。